Untitled

CDC Clinician Outreach and Communication Activity (COCA) presents….”Johnson & Johnson/Janssen COVID-19 Vaccine and Thrombosis with Thrombocytopenia Syndrome (TTS): Update for Clinicians” call.

This COCA Call will present the latest evidence on thrombosis with thrombocytopenia syndrome (TTS) after administration of the Johnson & Johnson/Janssen COVID-19 vaccine. Speakers will discuss information on TTS and updated vaccine recommendations.

COCA Call Objectives  |  At the conclusion of the session, the participant will be able to accomplish the following:

1. Cite background information on the topic covered during the presentation.
2. Discuss CDC’s role in the topic covered during the presentation.
3. Describe the topic’s implications for clinicians.
4. Discuss concerns and/or issues related to preparedness for and/or response to urgent public health threats.
5. Promote health improvement, wellness, and disease prevention in cooperation with patients, communities, at-risk populations, and other members of an interprofessional team of healthcare providers.

Presenters:

Sara Oliver, M.D.  |  LCDR, U.S. Public Health Service  |  Co-lead, Advisory Committee for Immunization Practices COVID-19 Vaccines Work Group  |  COVID-19 Response  |  Centers for Disease Control and Prevention

Tom Shimabukuro, M.D., MPH, MBA  |  CAPT, U.S. Public Health Service  |  Vaccine Safety Team Lead  |  COVID-19 Response  |  Centers for Disease Control and Prevention

Target Audience:  Healthcare professionals

Continuing Education: Continuing Education (CE) will not be provided for this call.

Advaanced registration is not required.